Teleflex Inc
NYSE:TFX

Watchlist Manager
Teleflex Inc Logo
Teleflex Inc
NYSE:TFX
Watchlist
Price: 191.71 USD 0.56% Market Closed
Market Cap: 8.9B USD
Have any thoughts about
Teleflex Inc?
Write Note

Teleflex Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Teleflex Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Teleflex Inc
NYSE:TFX
Cash & Cash Equivalents
$243.2m
CAGR 3-Years
-20%
CAGR 5-Years
-1%
CAGR 10-Years
-2%
Becton Dickinson and Co
NYSE:BDX
Cash & Cash Equivalents
$1.7B
CAGR 3-Years
-9%
CAGR 5-Years
26%
CAGR 10-Years
-1%
Boston Scientific Corp
NYSE:BSX
Cash & Cash Equivalents
$2.5B
CAGR 3-Years
9%
CAGR 5-Years
55%
CAGR 10-Years
26%
Stryker Corp
NYSE:SYK
Cash & Cash Equivalents
$3.9B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
11%
Abbott Laboratories
NYSE:ABT
Cash & Cash Equivalents
$7B
CAGR 3-Years
-9%
CAGR 5-Years
11%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash & Cash Equivalents
$2.4B
CAGR 3-Years
21%
CAGR 5-Years
20%
CAGR 10-Years
17%
No Stocks Found

Teleflex Inc
Glance View

Market Cap
8.9B USD
Industry
Health Care

Teleflex Inc. is a global provider of medical technologies designed to enhance patient outcomes and improve efficiency in healthcare systems. Founded in 1943, the company has established itself as a leader in the medical device industry, focusing primarily on areas such as vascular access, anesthesia, urology, and surgical interventions. Teleflex's innovative products, ranging from catheters to advanced surgical tools, are essential in diverse medical settings, including hospitals and outpatient facilities. With a commitment to research and development, Teleflex invests heavily in new technologies, positioning itself to address the evolving needs of healthcare professionals and patients worldwide. For investors, Teleflex represents a compelling opportunity in the fast-growing healthcare sector, bolstered by its robust portfolio of patented offerings and strong market presence. The company has demonstrated resilience and adaptability, maintaining steady revenue growth and profitability even amidst shifting market dynamics. With an expanding global footprint and strategic acquisitions aimed at enhancing its product line, Teleflex not only aims to capture emerging trends in healthcare but also to deliver consistent value to its shareholders. As the demand for innovative medical solutions continues to rise, Teleflex is well-poised to play a pivotal role in shaping the future of patient care while presenting a potentially lucrative investment opportunity.

TFX Intrinsic Value
274.05 USD
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Teleflex Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
243.2m USD

Based on the financial report for Sep 29, 2024, Teleflex Inc's Cash & Cash Equivalents amounts to 243.2m USD.

What is Teleflex Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-2%

Over the last year, the Cash & Cash Equivalents growth was -72%. The average annual Cash & Cash Equivalents growth rates for Teleflex Inc have been -20% over the past three years , -1% over the past five years , and -2% over the past ten years .

Back to Top